Both in Pharmaceuticals
Insmed vs Alnylam Pharmaceuticals
Over the past year INSM returned −39.8% and ALNY returned −62.0%; their daily moves had a correlation of 0.03.
INSM −39.8% ALNY −62.0%Growth of $1, one year, split-adjusted
| Metric | INSM | ALNY |
|---|---|---|
| Price | $110.00 | $161.08 |
| Market cap | $24.13B | $21.57B |
| Today | +5.32% | +0.74% |
| 1 month | +4.5% | −28.1% |
| 6 months | −19.8% | −46.8% |
| Year to date | −36.8% | −59.5% |
| 1 year | −40.9% | −62.9% |
| Revenue growth (YoY) | +268.4% | +16.7% |
| Gross margin | 85.1% | 75.2% |
| Net margin | −19.1% | 148.6% |
| P/E (TTM) | — | 7.9× |
| Price / sales | 15.9× | 4.3× |
| Net cash | $569.9M | $2.57B |
| Dividend yield | — | — |
| Volatility (60d) | 48.6% | 72.8% |
| Short % of float | 6.3% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).